JNC-7 definition of hypertension needs alteration

Size: px
Start display at page:

Download "JNC-7 definition of hypertension needs alteration"

Transcription

1 JNC-7 definition of hypertension needs alteration Suresh T Yavagal, MD DM* Ravikant Patil, DM** Prabhu C Halakatti, DM*** Suresh V Patted, DM*** Sameer Ambar, DM** Basavprabhu Amarkhed, MD***** PF Kotur, MD**** ABSTRACT OBJECTIVES By altering JNC-7 definition of hypertension as per our modified definition, we tried to find out the difference in prevalence of hypertension. Our modified definition is 1 mmhg less than JNC-7 criteria. METHODS We did the analysis of data collected in Belgaum Hypertension Prevalence Study conducted by KLE University Belgaum; to know the difference between the JNC-7 classified group and modified classification what we thought can change the hypertension statistics. RESULTS According to JNC-7, only 16.3% population in our study were in normal group while 41.1% had come in pre-hypertension group and 42.6% were in hypertensive group. According to our proposed modified definition, nearly double the populations i.e. 37.4% were in normal group, 40.2% remained in pre-hypertension group and only 22.4% were in hypertension group. CONCLUSION This statistics significantly altered prevalence of hypertension from 42.6% to 22.4% indicating that by making 1 mmhg alteration in number, the prevalence could be brought down by 20.2%. This simple alteration of figure by 1 mmhg can put more than 20% of people in normal group as compared to pre-hypertensive group of JNC-7, thereby reducing the agony and psychological torture. INTRODUCTION Hypertension, is the most important public health problem worldwide till date and its impact is expected to increase over the *Professor, HOD, **Associate Professor of Cardiology, ***Professor of Cardiology, ****Registar, KLE University, *****PG Student, DM Cardiology. Correspondence: Dr. ST Yavagal, MD DM, Professor and HOD, Cardiology, Jawahar Lal Nehru Medical College, KLES Dr. Prabhakar Kore Hospital & MRC, Nehru Nagar, Belgaum , Karnataka. Ph: styavagal@yahoo.co.in next 20 years as economically developing nations improve sanitation, infant mortality and childhood immunization rates. 1 The prevalence of hypertension in adults is expected to grow from 26.4% (in 2000) to 29.2% in 2025, with most of the growth from 972 million to projected 1.56 billion affected people occurring outside of North America and Europe i.e. in the developing countries. This global epidemic of high blood pressure is expected to shift the burden of disease so that the heart disease will become the most common cause of death worldwide by the year In India, cardiovascular diseases caused 2.3 million deaths in 1990 and by 2020, and this number is projected double. Recent studies by using JNC criteria have shown that hypertension is present in 25% of urban and 10% of rural subjects in India. In addition, this percentage translates into absolute number of 42 million persons in rural and 45 million in urban areas. 3 The definition of hypertension changed dramatically over time in response to better understanding of hypertension, pathophysiology, and studies of blood pressures from the diverse communities; landmark studies of BP related health outcomes. Should the usual BP in a population be considered normal? Should the rise according to age be considered abnormal? All those and other kind of questions related to blood pressure had found answer from huge data of both clinical and epidemiological studies. Sir George Pickering clearly articulates in 1968, when he said, Arterial pressure is a quantity and its adverse effect is related numerically to it. The dividing line (between normal BP and hypertension) is nothing more than an artifact. 4 The multiple risk factor intervention trial (MRFIT), which included more than 5,50,000 male participants, confirmed a continuous and graded influence of both systolic blood pressure (SBP) and diastolic blood pressure (DBP) on coronary heart disease mortality, extending down to SBP of 120 mmhg. 5,6 Over the time various expert panels as well as JNC have changed their definition as more and more data became available. The most recent report of JNC-7, published in 2003, defines the normal BP as lower than 120/80 mmhg. Further JNC-7 states that individual with SBP from mmhg or DBP mmhg should be considered pre-hypertensive and health promoting lifestyle modifications are recommended for those person. 7 But taking in account psychology of general public, very word of hypertension, puts the person next to you in panic. Once we label the person as hypertensive or prehypertensive, it will have a serious negative impact on the social, personal, and family life of the patient. Various studies which measured quality of life (QoL) index in a patient who are labeled as hypertensive, even if adequately controlled with drugs; have shown negative impacts. Most of the studies, including report of a National Survey of General Practitioners, identified serious gap in knowledge and practice regarding diagnosis and management of hypertension. 8 Similar finding are also reported from the developed countries In our observation, most of the general physicians have a habit of writing 120/80 mmhg as normal blood pressure, and even most of them do not give much importance JICC Vol 1 Issue 1 5

2 Yavagal, et al or are ignorant about making genuine effort of beat-by-beat blood pressure measurement and error of 1 2 mmhg is present in most of reading. Even as recommended by JNC more than one reading is taken in very few cases. 12 So, if we alter the definition of JNC by just 1 mmhg, higher limit definition of pre-hypertension will include BP 121/ 81 mmhg and similarly for stage 1 or stage 2 hypertension, there could be a significant difference in the statistics of the hypertension. So, we did the analysis of data collected in Belgaum Hypertension Prevalence Study conducted by KLE University, Belgaum to know the difference between the JNC-7 classified group and modified classification, what we thought can change the hypertension statistics (Table 1). MATERIAL AND METHODS Aim of Study To find out difference in the prevalence of hypertension by altering JNC-7 definition of hypertension, as per our modified definition. Methods We decided to derive our data from KLE University Belgaum Hypertension Detection Study. In this study, it was decided to screen all persons above 30 years of Belgaum city for any hypertension. To collect correct figures it is ideal to go door to door and screen the people. But it is a difficult task. Therefore, it was decided to have around 225 centers covering the entire city of Belgaum, and people were requested to come to one of the center and get their BP checked. All staff members of Jawaharlal Nehru Medical and Dental College, staff and doctors of KLE Hospital, and Ayurvedic Colleges participated. Each center had 5 doctors. Thus, around 1100 doctors were involved in recording blood pressure and screening of public. The program was organized on Sunday, April 6, 2008 on the eve of World Health Day (April 7, 2008). Since April 7 marked the Ugadi festival, the camp was organized on April 6, All doctors of Belgaum city participated in this camp. Indian Medical Association (Belgaum), Cardiological Society of India, north-west Karnataka chapter and Indian College of Cardiology participated as co-sponsors of the project. All students of KLE University formed mobilizing teams to bring public to the screening centers. Other KLE institutions (non-medical) students worked as volunteers. All together nearly, 2000 students worked as volunteers to mobilize public. All city corporators and their party workers also participated in mobilizing work. The following data was collected, name, age, sex, previous history of hypertension, diabetes, cerebrovascular accidents, visual assessment of obesity, height, weight, abdominal girth at the level of umbilicus, etc. Blood pressure was recorded in sitting posture. Appearance of the sounds was taken as systolic pressure and disappearance of sounds was taken as diastolic pressure. When the pulse pressure was more than 60 then muffling of the sound was taken as diastolic pressure, written instructions were given in the data-collecting book. RESULTS OF THE STUDY Data operators entered all data collected into computer and with their help, data was analyzed. In total people attended the camp, (63.20%) were males and (36.80%) were females. All though the camp was organized to screen all people above 30 years yet 4106 (7.30%) were below 30 years. Only persons above 30 years i.e were taken for analysis (Tables 2, 3, 4). DISCUSSION There are multiple single center studies on prevalence of hypertension available across the country. However, there is no multicentric national prevalence data. Over the years with changing definition, a lower level of pressure (140/90 mmhg) is being used as a cut-off point to define hypertension as compared to earlier studies, which used higher levels of pressure (160/95 mmhg). This vitiates any assessment of trends of hypertension prevalence over the past few decades. Nevertheless, there appears to be a steady increase in hypertension prevalence over the last 50 years, more in urban than in rural areas. Using cut-off 160/95 mmhg for diagnosis of hypertension, studies conducted in 1950s in urban Indian populations revealed that the prevalence of hypertension ranged between 3.03% and 6.19%. Using the same criteria, the prevalence increased to 6.43% and % in Based on the revised diagnostic BP criteria of 140/90 mmhg studies from Mumbai have reported a prevalence rate of % while in Jaipur it was 36.9%. Therefore, changing definition has definitely increased prevalence of hypertension. Table 1 Criteria of blood pressure classification. JNC-7 Classification Proposed Classification Normal < 120/80 mmhg Normal < 121/81 mmhg Pre-hypertension /80 89 mmhg Pre-hypertension /81 90 mmhg Stage I hypertension /90 99 mmhg Stage I hypertension / mmhg Stage II hypertension 160/100 mmhg Stage II hypertension > 160/100 mmhg JICC Vol 1 Issue 1 6

3 JNC-7 definition of hypertension needs alteration Table 2 Age and sex distribution. Age group Male Female % % % % % % % % % % % % % % % % % % % % % 100 and above 4 0.0% 00 0% 4 0.0% % % % population screened = population screened (30 years and above) = were below 30 years hence, not included in the analysis. Table 3 Distribution of blood pressure according to JNC-7 definition. Blood pressure Male Female Normal (< 120/80 mmhg) % % % Pre-hypertensive 120/80 139/89 mmhg % % % Hypertensive 140/90 mmhg and above % % % % % % Table 4 Distribution of blood pressure (with modified definition). Age group Male Female Normal (< 121/81 mmhg) % % % Pre-hypertensive 121/81 140/90 mmhg % % % Hypertensive 141/90 mmhg and above % % % % % % According to JNC-7 only 16.3% population in our study was in normal groups while 41.2% had come in pre-hypertension group and 42.6% were in hypertensive group (Figure 1). According to our modified definition nearly double the population i.e. 37.4% was in normal group, 40.2% remained in pre-hypertension group and only 22.4% were remained in hypertension group (Figure 2). This statistics significantly altered prevalence of hypertension from 42.6% to 22.4%. That means just making 1mm alteration in number can bring down the prevalence by 20.2%, which is considering worldwide epidemic of hypertension is a very big number. Therefore, this 20.2% population, which needs drug treatment for hypertension according to JNC-7, our modified definition recommends only lifestyle modification. Even only 16.3% were normal according to JNC-7, but our modified definition converts that number to 37.4%. Therefore, JNC-7 labels this extra 21.1% population as pre-hypertensive and setting them in panicky situation. Our proposed definition by altering 1 mmhg calculation in JNC-7 definition had made the big difference to the population screened in our study. This study certainly augurs good news to the treating physicians. Next question arises immediately after considering this modified JNC-7 classification, whether ignoring 1 mmhg rise in BP translates into fatal cardiac and non-cardiac adverse effects of hypertension. Framingham Heart Study investigators developed the risk calculators for chronic heart disease (CHD). The simplest of these was adopted by the third adult treatment panel of the National Cholesterol Education Program 15 which states that cardiovascular disease risk is increased 2.5-folds in women and 1.6-folds in men with high normal BP (SBP mmhg or DBP mmhg). 16,17 Thus, the studies considered the range rather than 1 mmhg change. In both men and women, each 20 mmhg difference of SBP or approximately 10 mmhg diastolic BP was associated with more than two-folds difference in stroke death rates and with a twofolds difference in death rates from ischemic heart disease (IHD), each 10 mmhg lower SBP is associated with 33% decreased risk of stroke. 18 As all the studies, showed associated risk of hypertension when measured in range and not with 1 mmhg difference, so altering definition will not definitely change the end measurements. JICC Vol 1 Issue 1 7

4 Yavagal, et al Percentage (%) Normal (< 120/80 mmhg) Pre-hypertensive 120/80 mmhg 139/89 mmhg Hypertensive 140/90 mmhg and above Male 8.90% 25.90% 28.30% 63.20% Female 7.40% 15.20% 14.20% 36.80% 16.30% 41.20% 42.60% % Figure 1 Graph showing distribution according to JNC-definition Percentage (%) Normal (< 121/81 mmhg) Pre-hypertensive 121/81 mmhg 140/90 mmhg Hypertensive 141/90 mmhg and above Male 22.00% 26.40% 14.80% 63.20% Female 15.40% 13.80% 7.60% 36.80% 37.40% 40.20% 22.40% % Figure 2 Graph showing distribution of blood pressure according to modified definition. However, why a new definition? The public health services in developing countries particularly Asia and Africa including China, are dysfunctional. 19,20 The vast majority of the population in these countries seek care from allopathic doctors, as well as their traditional branches of medicine like Unani, Ayurveda, Homeopathy, etc. 21,22 Most of the studies from these countries reported marked deficiencies in knowledge and approach of family physicians from these countries relating diagnosis and management of high blood pressures and identified serious limitation in current practice. 23 Therefore, the measurement taken by most of the family physicians in reality is not accurate. Moreover, most of these doctors write 120/80 mmhg as a normal blood pressure, which is a very common phenomenon worldwide. That is why epidemiological studies, based on single measurement taken by the family physicians, will overestimate the prevalence of hypertension statistically. The estimated cost of hypertension and its treatment in United States alone in 2006 is 63.5 billion. Worldwide the cost is six times the above value, which involves lifestyle modification JICC Vol 1 Issue 1 8

5 JNC-7 definition of hypertension needs alteration to drug treatment. Even in United States over the last 15 years, the cost of antihypertensive drugs has increased more than 7 times the inflation rates. 24 Our modified definition will prevent the use of antihypertensive treatment in nearly half the JNC-7 population treated as hypertensive group, which can nearly bring down the cost involved by 50% to ease the already overburdened world economies. 25 So logistically speaking, if we consider the hard and ground level facts of measuring diagnosing and treating hypertension, our modified definition of JNC-7 will bring down the proposed prevalence of the hypertension in the population. This will in turn decrease the agony and psychological torture of significant number of population who have been labeled as pre-hypertensive or hypertensive. In addition, we recommend to Indian Cardiology Society as well as World Cardiology Society to initiate a comprehensive program for physician and family physicians to become aware about measurement of blood pressure in more careful and correct way. REFERENCES 1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365: Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002;360: Rodgers A, Lawes C, MacMahon S. Reducing the global burden of blood pressure related cardiovascular disease. J Hypertens 2000; 18(Suppl 1):S Pickering G. In: High Blood Pressure, 2nd ed. New York: Grune and Stratton, 1968: Kannel WB, Vasan RS, Levy D. Is the relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values? Hypertension 2003;42: Neaton JD, Kuller L, Stamler J, et al. Impact of systolic and diastolic blood pressure on cardiovascular mortality. In: Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn. Laragh JH, Brenner BM, eds, New York: Raven Press 1995: National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003;42: Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States: JAMA 2003;290: Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19: Sisson SD, Rastegar D. Physician familiarity with diagnosis and management of hypertension according to JNC-7 guideline. J Clin Hypertens 2006;8: Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens (Greenwich) 2000;2: Hagemeister J, Scheider CA, Barabas S, et al. Hypertension guidelines and their limitations: the impact of physicians compliance as evaluated by guideline awareness. J Clin Hypertens 2001;19: Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J 2005;150: Cambell M, Grimshaw, Steen N. Sample size calculation for cluster randomized trials. J Health Serv Res Policy 2000;5: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: Vasan RS, Larson MG, Leip EP, et al. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275: Lawes CMM, Bennett DA, Feigin VL, et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35: Liu GG, Zhao Z, Cai R, Yamada T. Equity in health care access to: assessing the urban health insurance reform in China. Soc Sci Med 2002; 55: Singh P, Yadav RJ, Pandey. A utilization of indigenous systems of medicine and homoeopathy in India. Indian J Med Res 2005;122: Jafar TH, Levey AS, Jafary FH, et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens 2003;21: Ahmad K, Jafar TH. Prevalence and determinants of blood pressure screening in Pakistan. J Hypertens 2005;23: Jafar TH, Jessani S, Jafary FH, et al. General practitioners approach to hypertension in urban Pakistan disturbing trends in practice. Circulation 2005;111: Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113: Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States : a rising tide. Hypertension 2004;44: JICC Vol 1 Issue 1 9

Prevalence of Hypertension in Semi-Urban area of Nepal

Prevalence of Hypertension in Semi-Urban area of Nepal ORIGINAL ARTICLE Prevalence of Hypertension in Semi-Urban area of Nepal Koju R*, Manandhar K*, Gurung R*, Pant P*, Bedi TRS* *Department of Internal Medicine, Dhulikhel Hospital KUH ABSTRACT Hypertension

More information

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,

More information

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia (2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,

More information

Prevalence, awareness of hypertension in rural areas of Kurnool

Prevalence, awareness of hypertension in rural areas of Kurnool Original article: Prevalence, awareness of hypertension in rural areas of Kurnool Dr. Sudhakar Babu*, Dr.Aruna MS** *Associate Professor, Dept of Community Medicine, Vishwa Bharathi Medical College Kurnool,

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

Managing HTN in the Elderly: How Low to Go

Managing HTN in the Elderly: How Low to Go Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular

More information

Hypertension awareness, treatment, and control

Hypertension awareness, treatment, and control O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles

More information

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario M Paul Anand Consultant Physician, Lady Ratan Tata Medical Centre, M. Karve Road, Cooperage, Mumbai Executive Editor, API Textbook of Medicine Introduction

More information

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:

More information

Update on Current Trends in Hypertension Management

Update on Current Trends in Hypertension Management Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student

More information

RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY

RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY Health and Population - Perspectives and Issues 37 (1 & 2), 40-49, 2014 RISK FACTORS FOR HYPERTENSION IN INDIA AND CHINA: A COMPARATIVE STUDY FuJun Wang*, V. K. Tiwari** and Hao Wang*** ABSTRACT To identify

More information

Prevalence of Cardiac Risk Factors among People Attending an Exhibition

Prevalence of Cardiac Risk Factors among People Attending an Exhibition IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 3, Issue 6 Ver. IV (Nov.-Dec. 2014), PP 4-51 Prevalence of Cardiac Risk Factors among People Attending

More information

Frequency of Isolated Systolic Hypertension in Elderly Hypertensives

Frequency of Isolated Systolic Hypertension in Elderly Hypertensives ORIGINAL ARTICLE Frequency of Isolated Systolic Hypertension in Elderly Hypertensives HINA HUSSAIN, HUMA HUSSAIN ABSTRACT Aim: To study frequency of isolated systolic hypertension in elderly hypertensive.

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose. JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I

More information

As a major risk factor for cardiovascular (CV)

As a major risk factor for cardiovascular (CV) R e v i e w P a p e r Assessment of Global Risk: A Foundation for a New, Better Definition of Hypertension Thomas D. Giles, MD The prevalence of individuals with increased blood pressure (BP) is growing.

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 N OVEMBER 1, 2001 NUMBER 18 IMPACT OF HIGH-NORMAL BLOOD PRESSURE ON THE RISK OF CARDIOVASCULAR DISEASE

More information

Hypertension is an important global public

Hypertension is an important global public IN THE LITERATURE Blood Pressure Target in Individuals Without Diabetes: What Is the Evidence? Commentary on Verdecchia P, Staessen JA, Angeli F, et al; on behalf of the Cardio-Sis Investigators. Usual

More information

A pre experimental study to assess the effect of administration of pomegranate juice among prehypertensive men and women aged between 25-45

A pre experimental study to assess the effect of administration of pomegranate juice among prehypertensive men and women aged between 25-45 2015; 1(11): 597-601 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 2015; 1(11): 597-601 www.allresearchjournal.com Received: 04-08-2015 Accepted: 06-09-2015 Anoop Masih Sandhu Assistant

More information

Hypertension in the very old. Objectives: Clinical Perspective

Hypertension in the very old. Objectives: Clinical Perspective Harvard Medical School Hypertension in the very old Ihab Hajjar, MD, MS, AGSF Associate Director, CV Research Lab Assistant Professor of Medicine, Harvard Medical School Objectives: Describe the clinical

More information

Characteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study

Characteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study ORIGINAL PAPER Characteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study Yi Zhang, MD, PhD; 1 Helene Lelong, MD; 2 Sandrine

More information

The presence of cardiovascular disease risk factors, clinical

The presence of cardiovascular disease risk factors, clinical The Impact of JNC-VI Guidelines on Treatment Recommendations in the US Population Paul Muntner, Jiang He, Edward J. Roccella, Paul K. Whelton Abstract Using epidemiological and clinical trial evidence,

More information

A Needs Assessment of Hypertension in Georgia

A Needs Assessment of Hypertension in Georgia A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine

More information

Prevalence, Awareness and Control of Hypertension in Chennai - The Chennai Urban Rural Epidemiology Study (CURES 52)

Prevalence, Awareness and Control of Hypertension in Chennai - The Chennai Urban Rural Epidemiology Study (CURES 52) Original Article# Prevalence, Awareness and Control of Hypertension in Chennai - The Chennai Urban Rural Epidemiology Study (CURES 52) V Mohan*, M Deepa*, S Farooq*, M Datta**, R Deepa* Abstract Objective

More information

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS

A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS Original Article A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS Renu Lohitashwa, Parwati Patil ABSTRACT Overweight

More information

Prevalance of Lifestyle Associated Risk Factor for Non- Communicable Diseases among Young Male Population in Urban Slum Area At Mayapuri, New Delhi

Prevalance of Lifestyle Associated Risk Factor for Non- Communicable Diseases among Young Male Population in Urban Slum Area At Mayapuri, New Delhi IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 7 Ver. 17 (July. 2018), PP 59-64 www.iosrjournals.org Prevalance of Lifestyle Associated Risk

More information

JMSCR Vol 04 Issue 05 Page May 2016

JMSCR Vol 04 Issue 05 Page May 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i5.14 Study on ECG Changes in Chronic hypertensive

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

The problem of uncontrolled hypertension

The problem of uncontrolled hypertension (2002) 16, S3 S8 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh The problem of uncontrolled hypertension Department of Public Health and Clinical Medicine, Norrlands

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

International Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN

International Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN ISSN 2278-7763 295 Study of Prescriptive Patterns of Antihypertensive Drugs in South India Popuri Rupa Sindhu, Malladi Srinivas Reddy St. Peters Institute of Pharmaceutical Sciences, Hanamkonda, Warangal-506001,

More information

When should you treat blood pressure in the young?

When should you treat blood pressure in the young? ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

Trends In CVD, Related Risk Factors, Prevention and Control In China

Trends In CVD, Related Risk Factors, Prevention and Control In China Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology

More information

Slide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides,

Slide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides, 3/23/2016 1 This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides, containing source materials and references. 2 The Framingham,

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Cardiovascular disease (CVD), including stroke, is the

Cardiovascular disease (CVD), including stroke, is the Review: Clinical Cardiology: New Frontiers Hypertensive Therapy: Part I Veronica Franco, MD; Suzanne Oparil, MD; Oscar A. Carretero, MD Cardiovascular disease (CVD), including stroke, is the most common

More information

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study (2004) 18, 623 629 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prevalence, awareness, treatment and control of hypertension in employees of

More information

An Epidemiological Study of Hypertension and Its Risk Factors in Rural Population of Bangalore Rural District

An Epidemiological Study of Hypertension and Its Risk Factors in Rural Population of Bangalore Rural District AJMS Al Ameen J Med Sci (2 012 )5 (3 ):2 6 4-2 7 0 (A US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 C O D E N : A A J M B G ORIGI NAL ARTICLE An Epidemiological Study of Hypertension

More information

Essential Hypertension Management Considerations By Elaine Lewis, ND

Essential Hypertension Management Considerations By Elaine Lewis, ND Essential Hypertension Management Considerations By Elaine Lewis, ND Elaine Lewis, ND Research Resident, Canadian College of Naturopathic Medicine 1255 Sheppard Avenue East North York, Ontario Back To

More information

Major Risk Factors and Coronary Heart Disease: Much Has Been Achieved but Crucial Challenges Remain*

Major Risk Factors and Coronary Heart Disease: Much Has Been Achieved but Crucial Challenges Remain* Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01515-7 EDITORIAL

More information

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA)

THE NEW ARMENIAN MEDICAL JOURNAL DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) THE NEW ARMENIAN MEDICAL JOURNAL Vol.5 (2011), Nо 2, p.29-34 DISTRIBUTION, AWARENESS, TREATMENT, AND CONTROL OF ARTERIAL HYPERTENSION IN YEREVAN (ARMENIA) Zelveian P.H. 1, 2, Podosyan G.A. 2 1 Institute

More information

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama

More information

Normal blood pressure values as perceived by normotensive and hypertensive subjects

Normal blood pressure values as perceived by normotensive and hypertensive subjects ORIGINAL ARTICLE Normal blood pressure values as perceived by normotensive and hypertensive subjects (2003) 17, 87 91 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh

More information

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution

More information

HYPERTENSION; THE ICE BERG

HYPERTENSION; THE ICE BERG The Professional Medical Journal DOI: 10.17957/TPMJ/15.2930 ORIGINAL PROF-2930 HYPERTENSION; THE ICE BERG 1. Senior Lecturer (Community Medicine). RIHS Islamabad. 2. Assistant Professor, Department of

More information

Health Benefits of Lowering Sodium Intake in the US

Health Benefits of Lowering Sodium Intake in the US Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology

More information

Original Article Obesity and Hypertension: Time To Face Reality Pak Armed Forces Med J 2016; 66 (Suppl-1): S36-40

Original Article Obesity and Hypertension: Time To Face Reality Pak Armed Forces Med J 2016; 66 (Suppl-1): S36-40 Original Article Obesity and Hypertension: Time To Face Reality Pak Armed Forces Med J 2016; 66 (Suppl-1): S36-40 FREQUENCY OF OBESITY AND HYPERTENSION IN ARMED FORCES: IT IS TIME TO FACE REALITY Sultan

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Prevalence and risk factors of hypertension, among adults residing in an urban area of North India

Prevalence and risk factors of hypertension, among adults residing in an urban area of North India Available online at www.ijpab.com INTERNATIONAL JOURNAL OF PURE & APPLIED BIOSCIENCE ISSN: 2320 7051 Int. J. Pure App. Biosci. 3 (2): 338-344 (2015) Research Article Prevalence and risk factors of hypertension,

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

47 Hypertension in Elderly

47 Hypertension in Elderly 47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary

More information

Therapeutic Lifestyle Changes and Drug Treatment for High Blood Cholesterol in China and Application of the Adult Treatment Panel III Guidelines

Therapeutic Lifestyle Changes and Drug Treatment for High Blood Cholesterol in China and Application of the Adult Treatment Panel III Guidelines Therapeutic Lifestyle Changes and Drug Treatment for High Blood Cholesterol in China and Application of the Adult Treatment Panel III Guidelines Paul Muntner, PhD a,b,, Dongfeng Gu, MD c, Robert F. Reynolds,

More information

Overview of the outcome trials in older patients with isolated systolic hypertension

Overview of the outcome trials in older patients with isolated systolic hypertension Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated

More information

Elements for a public summary

Elements for a public summary VI.2 Elements for a public summary VI.2.1Overview of disease epidemiology 1 Losartan is indicated for: Treatment of essential hypertension in adults and in children and adolescent 6 18 years of age. Treatment

More information

Controlling Hypertension in Primary Care: Hitting a moving target?

Controlling Hypertension in Primary Care: Hitting a moving target? Controlling Hypertension in Primary Care: Hitting a moving target? David J. Hyman, MD,MPH Professor of Medicine and Family & Community Medicine Chief, Section General Medicine Baylor College of Medicine

More information

Blood Pressure Targets: Where are We Now?

Blood Pressure Targets: Where are We Now? Blood Pressure Targets: Where are We Now? Diana Cao, PharmD, BCPS-AQ Cardiology Assistant Professor Department of Clinical & Administrative Sciences California Northstate University College of Pharmacy

More information

HYPERTENSION AND HEART FAILURE

HYPERTENSION AND HEART FAILURE HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his

More information

When should blood pressure be lowered? Should treatment be guided by blood pressure values or total cardiovascular risk?

When should blood pressure be lowered? Should treatment be guided by blood pressure values or total cardiovascular risk? OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Editorial J Hypertens Res (2016) 2(2):47 51 When should blood pressure be lowered? Should treatment be guided

More information

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care

Hypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider

More information

Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines

Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines American Journal of Pharmacology and Toxicology Original Research Paper Prescription Pattern of Anti-Hypertensive Drugs in Adherence to JNC- 7 Guidelines 1 Krishna Murti, 1 M. Arif Khan, 1 Akalanka Dey,

More information

Clinical and Economic Summary Report. for Employers

Clinical and Economic Summary Report. for Employers Clinical and Economic Summary Report for Employers Magaly Rodriguez de Bittner, PharmD, CDE, FAPhA Director, P 3 Program Dawn Shojai, PharmD Assistant Director, P 3 Program P 3 Clinical & Economic Summary

More information

Managing the global burden of cardiovascular disease

Managing the global burden of cardiovascular disease European Heart Journal Supplements (2002) 4 (Supplement F), F2 F6 Managing the global burden of cardiovascular disease B. Neal, N. Chapman and A. Patel Institute for International Health, Sydney, New South

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Serum sodium and potassium levels in newly diagnosed essential hypertensive patients in Government Dharmapuri Medical College, Dharmapuri

Serum sodium and potassium levels in newly diagnosed essential hypertensive patients in Government Dharmapuri Medical College, Dharmapuri Original Research Article Serum sodium and potassium levels in newly diagnosed essential hypertensive patients in Government Dharmapuri Medical College, Dharmapuri Murugan 1, Sathvika 2* 1 Professor, 2

More information

Increased variance in blood pressure distribution and changing hypertension. prevalence in an urban Indian population. In

Increased variance in blood pressure distribution and changing hypertension. prevalence in an urban Indian population. In (23) 17, 535 54 & 23 Nature Publishing Group All rights reserved 95-924/3 $25. www.nature.com/jhh ORIGINAL ARTICLE Increased variance in blood pressure distribution and changing hypertension prevalence

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,

More information

Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension

Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension 525 Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension PHIMDA Kriangsak 1* and CHOTNOPARATPAT Paiboon 2 1 Diabetes and Hypertension Clinic,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Moran A, Zhao D, Gu D, et al. The Future Impact of Population

More information

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients? Commentary on Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators.

More information

Why Do We Treat Obesity? Epidemiology

Why Do We Treat Obesity? Epidemiology Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article The Prevalence of Hypertension and Task Analysis of Corporates Working in Shweta Bajaria 1,

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

A Study of Prevalence of Hypertension in Employees of Bangalore Metropolitan Transport Corporation (BMTC)

A Study of Prevalence of Hypertension in Employees of Bangalore Metropolitan Transport Corporation (BMTC) Hamdard Medicus 11 A Study of Prevalence of Hypertension in Employees of Bangalore Metropolitan Transport Corporation (BMTC) Abdul Haseeb Ansari, Mohammed Zulkifle and Mohammed Shakir Department of Tahaffuzi

More information

290 Biomed Environ Sci, 2016; 29(4):

290 Biomed Environ Sci, 2016; 29(4): 290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

CONTRIBUTING FACTORS FOR STROKE:

CONTRIBUTING FACTORS FOR STROKE: CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING

More information

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk

More information

Hypertension in Adults Across the Age Spectrum

Hypertension in Adults Across the Age Spectrum ORIGINAL CONTRIBUTION Hypertension in Adults Across the Age Spectrum Current Outcomes and Control in the Community Donald M. Lloyd-Jones, MD, ScM Jane C. Evans, DSc Daniel Levy, MD ELDERLY PERSONS ARE

More information

Working together Revista de cercetare [i interven]ie social\

Working together  Revista de cercetare [i interven]ie social\ Working together www.rcis.ro Revista de cercetare [i interven]ie social\ ISSN: 1583-3410 (print), ISSN: 1584-5397 (electronic) Selected by coverage in Social Sciences Citation Index, ISI databases ARTERIAL

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Causes of Poor BP control Rates

Causes of Poor BP control Rates Goals Of Hypertension Management in Clinical Practice World Hypertension League (WHL) Meeting Adel E. Berbari, MD, FAHA, FACP Professor of Medicine and Physiology Head, Division of Hypertension and Vascular

More information

Disclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012

Disclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012 How Should We ACCOMPLISH Good Blood Pressure Control In Our VETS? Disclosures No conflicts of interest to disclose Updates in the Management of HypertensionIn the Elderly Antoine T. Jenkins, Pharm.D.,

More information

YMCA S BLOOD PRESSURE SELF- MONITORING PROGRAM AHA CHECK. CHANGE. CONTROL. LEADERSHIP SUMMIT

YMCA S BLOOD PRESSURE SELF- MONITORING PROGRAM AHA CHECK. CHANGE. CONTROL. LEADERSHIP SUMMIT YMCA S BLOOD PRESSURE SELF- MONITORING PROGRAM AHA CHECK. CHANGE. CONTROL. LEADERSHIP SUMMIT - 2015 Y STRUCTURE: ASSOCIATIONS & BRANCHES OUR REACH 2 THE Y s APPROACH TO HEALTHY LIVING Impacting INDIVIDUALS

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

Hypertension and Cholesterol in the Elderly

Hypertension and Cholesterol in the Elderly Hypertension and Cholesterol in the Elderly Angela Sanford, MD Assistant Professor of Geriatrics Saint Louis University School of Medicine I have no relevant financial disclosures Cushman WC. The burden

More information

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions

More information

Gender differences in the prevalence of hypertension in a representative sample of Iranian population: the Isfahan Healthy Heart Program

Gender differences in the prevalence of hypertension in a representative sample of Iranian population: the Isfahan Healthy Heart Program ACTA BIOMED 2011; 82: 223-229 Mattioli 1885 O R I G I N A L A R T I C L E Gender differences in the prevalence of hypertension in a representative sample of Iranian population: the Isfahan Healthy Heart

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community/Population Health Meaningful Measure Area: Preventive

More information

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016 The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief

More information

Left Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient

Left Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient Left Ventricular Diastolic Dysfunction in South Indian Essential Hypertensive Patient Dr. Peersab.M. Pinjar 1, Dr Praveenkumar Devarbahvi 1 and Dr Vasudeva Murthy.C.R 2, Dr.S.S.Bhat 1, Dr.Jayaraj S G 1

More information

Prevalence study of hypertension among adults in an urban area of Jammu

Prevalence study of hypertension among adults in an urban area of Jammu 2014; 3 (2): 143-147 Available online at: www.jsirjournal.com Research Article ISSN 2320-4818 JSIR 2014; 3(2): 143-147 2014, All rights reserved Received: 01-03-2014 Accepted: 30-04-2014 Dr. Renu Rani

More information

Resistant hypertension (HTN) is defined as a

Resistant hypertension (HTN) is defined as a Original Paper Evaluation and Treatment of Resistant or Difficult-to-Control Hypertension David Wojciechowski, DO; Vasilios Papademetriou, MD; Charles Faselis, MD; Ross Fletcher, MD An observational study

More information